The eBPF Platform team owns the shared eBPF infrastructure inside the Datadog Agent, and is responsible for its reliability, performance, and evolution across a wide variety of Linux distributions and kernel versions. We build tooling and
Help us use technology to make a big green dent in the universe! Kraken powers some of the most innovative global developments in energy. We’re a technology company focused on creating a smart, sustainable energy system.
Alice & Bob is developing the first universal, fault-tolerant quantum computer to solve the world’s hardest problems.The quantum computer we envision building is based on a new kind of superconducting qubit: the Schrödinger cat qubit . In
Health can’t wait. Not for symptoms to get worse. Not for a six‑month appointment. Not for a system to catch up. But that’s exactly how healthcare works today. You wait, until you can’t. Alan exists to
Alice & Bob is developing the first universal, fault-tolerant quantum computer to solve the world’s hardest problems.The quantum computer we envision building is based on a new kind of superconducting qubit: the Schrödinger cat qubit . In
Company Overview DeepHealth, a RadNet company, is focused on delivering AI-powered solutions that improve population health, optimize radiology workflows, and drive earlier detection of disease. Our portfolio spans breast, lung, brain, prostate, and thyroid imaging AI,
Alice & Bob is developing the first universal, fault-tolerant quantum computer to solve the world’s hardest problems. The quantum computer we envision building is based on a new kind of superconducting qubit: the Schrödinger cat qubit .
Alice & Bob is developing the first universal, fault-tolerant quantum computer to solve the world’s hardest problems. The quantum computer we envision building is based on a new kind of superconducting qubit: the Schrödinger cat qubit .
Alaya.bio is a preclinical-stage biotech company pioneering a new generation of lentiviral-vector-based polymeric nanoparticles applied to the rapid and universal in situ manufacturing of CAR T-cells. Founded in July 2022 and based in Paris and New York,